Business
AstraZeneca puts COVID-19 vaccine trial on hold – The Australian Financial Review
The drug maker said its “standard review process triggered a pause to vaccination to allow review of safety data”.
AstraZeneca has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine candidate after a suspected serious adverse reaction in a study participant, health news website Stat News reported.
It quoted an AstraZeneca spokesperson as saying in a statement that the “standard review process triggered a pause to vaccination to allow review of safety data.
Nine leading US and European vaccine developers pledged on Tuesday to uphold scientific safety and efficacy standards for the…
-
Noosa News17 hours agoPill checking to resume in Queensland months after government axed funding
-
Business20 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Business21 hours agoASX shares are expensive. Here’s why you should be buying anyway
-
Noosa News21 hours agoNew Queensland Translink app receives scathing reviews as old app is retired